Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01979003 · ClinicalTrials.gov registry record · Early Phase 1
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
A Early Phase 1 study, sponsored by University of Arkansas.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
NCT01979003: Completed Early Phase 1 study, sponsored by University of Arkansas.
NCT01979003 is a Early Phase 1 study that has completed, run by University of Arkansas. The registered enrollment target is 100 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01979003, a Early Phase 1 study, has completed, sponsored by University of Arkansas.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
To determine if Fluorescein systemic injection during hysterectomy procedure can be useful in revealing the depth of endometrial cancer invasion.
Primary Outcome
Cancerous tissue will be measured to estimate the depth of invasion on the basis of physical appearance after receiving fluorescein injection prior to surgery. For each study subject, the paired difference in invasion depths determined using the Systemic Fluorescein Injection (SFI) versus Frozen Section (FS) methods will be calculated and expressed as a percentage of the FS-based invasion depth.
Interventions
- DRUG Fluorescein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-09 |
| Est. Completion | 2021-06-30 |
| Phase | Early Phase 1 |
What the finished NCT01979003 record still lists
NCT01979003 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% higher).
The record links to 0 conditions, and to 1 intervention - of which Fluorescein is the first listed.
NCT01979003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01979003 about?
NCT01979003 is a clinical study titled "Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion". To determine if Fluorescein systemic injection during hysterectomy procedure can be useful in revealing the depth of endometrial cancer invasion.
What is the current status of trial NCT01979003?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2014-09. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT01979003?
The interventions under investigation include: Fluorescein (DRUG).
Who is sponsoring clinical trial NCT01979003?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01979003's enrollment target sits among peer trials
100 184th of 2000 higher than 1,782 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia